Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy, Cancer Cell International

Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy - ScienceDirect

Molecular and therapeutic effect of CRISPR in treating cancer

Cells, Free Full-Text

PDF) Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

PD-1 gene editing by sgRNA/Cas9 RNP assembly in primary human T cells.

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy, Molecular Cancer

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

Cancers, Free Full-Text

The next wave of cellular immunotherapies in pancreatic cancer - ScienceDirect

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte -based adoptive T cell therapy: Molecular Therapy - Oncolytics

Molecular and therapeutic effect of CRISPR in treating cancer

Adoptive cellular therapies: the current landscape

News: PD-1 Targeted Cancer Immunotherapy Meets CRISPR - CRISPR Medicine